BROWN BROTHERS HARRIMAN & CO - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 65 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
BROWN BROTHERS HARRIMAN & CO ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$144,000
+71.4%
6,5000.0%0.00%
Q2 2021$84,0000.0%6,5000.0%0.00%
-100.0%
Q1 2021$84,000
-6.7%
6,5000.0%0.00%0.0%
Q4 2020$90,000
-6.2%
6,5000.0%0.00%0.0%
Q3 2020$96,000
-9.4%
6,5000.0%0.00%0.0%
Q2 2020$106,000
+12.8%
6,5000.0%0.00%0.0%
Q1 2020$94,000
-28.8%
6,5000.0%0.00%0.0%
Q4 2019$132,000
+277.1%
6,5000.0%0.00%
Q3 2019$35,000
-18.6%
6,5000.0%0.00%
Q2 2019$43,000
+2.4%
6,5000.0%0.00%
Q1 2019$42,000
-4.5%
6,5000.0%0.00%
Q4 2018$44,000
+2.3%
6,5000.0%0.00%
Q3 2018$43,000
+16.2%
6,5000.0%0.00%
Q2 2018$37,000
+8.8%
6,5000.0%0.00%
Q1 2018$34,000
+17.2%
6,5000.0%0.00%
Q4 2017$29,000
-29.3%
6,5000.0%0.00%
Q3 2017$41,000
+2.5%
6,5000.0%0.00%
Q2 2017$40,000
-16.7%
6,5000.0%0.00%
Q1 2017$48,0006,5000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders